Toxicological considerations for intravitreal drugs

By Penha Fernando M   Rodrigues Eduardo B   Furlani Bruno A   Dib Eduardo   Melo Gustavo B   Farah Michel E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 8, 2011-08 ,pp. : 1021-1034

Informa Healthcare

Access to resources Recommend Favorite

Toxicological considerations of acetylcholinesterase reactivators

By Voicu Victor   Rădulescu Flavian Ştefan   Medvedovici Andrei  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 31-50

Informa Healthcare

Access to resources Recommend Favorite

The Timing of Preclinical Toxicological Studies: Pharmaceutical Company Approaches to Toxicity Testing in Support of Initial Clinical Investigations

By Parkinson C.   Thomas K.E.   Lumley C.E.  

Regulatory Toxicology and Pharmacology, Vol. 23, Iss. 2, 1996-04 ,pp. : 162-172

Academic Press

Access to resources Recommend Favorite

Toxicological considerations for antithyroid drugs in children

By Karras Spiros   Tzotzas Themistoklis   Krassas Gerasimos E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 399-410

Informa Healthcare

Access to resources Recommend Favorite

Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals

By Vargas Hugo M   Amouzadeh Hamid R   Engwall Michael J  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite